Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2018 Aug;68(2):792-793.
doi: 10.1002/hep.30043.

Expanding Donor Pool for Liver Transplantation by Utilizing Hepatitis C Virus-Infected Donors for Uninfected Recipients

George Cholankeril  1 , Chiranjeevi Gadiparthi  2 , Donghee Kim  1 , Aijaz Ahmed  1
Affiliations
Comment

Expanding Donor Pool for Liver Transplantation by Utilizing Hepatitis C Virus-Infected Donors for Uninfected Recipients

George Cholankeril et al. Hepatology. 2018 Aug.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Potential conflict of interest: Dr. Ahmed consults for, advises for, and received grants from Gilead and Intercept. He consults for and advises for AbbVie, Jensen, and Shire.

Comment in

  • Reply.
    Chhatwal J, Bethea ED, Samur S, Chung RT. Chhatwal J, et al. Hepatology. 2018 Aug;68(2):793. doi: 10.1002/hep.30042. Hepatology. 2018. PMID: 29672882 No abstract available.

Comment on

References

    1. Chhatwal J, Samur S, Bethea ED, et al. Transplanting HCV-positive livers into HCV-negative patients with preemptive antiviral treatment: a modeling study. HEPATOLOGY 2017. December 9. doi: 10.1002/hep.29723 [Epub ahead of print] - DOI - PMC - PubMed
    1. Cholankeril G, Li AA, March KL, et al. Improved outcomes in HCV patients following liver transplantation during the era of direct-acting antiviral agents. Clin Gastroenterol Hepatol 2018;16:452–453. - PubMed
    1. Cholankeril G, Li AA, Yoo ER, Ahmed A. Direct-acting antiviral therapy and improvement in graft survival of hepatitis C liver transplant recipients. Transplantation 2017;101:e349. - PubMed
    1. Verna EC, Goldberg DS. Hepatitis C viremic donors for hepatitis C nonviremic liver transplant recipients: ready for prime time? Liver Transpl 2018;24:12–14. - PubMed
    1. Cholankeril G, Ahmed A. Alcoholic liver disease replaces hepatitis C virus infection as the leading indication for liver transplantation in the United States. Clin Gastroenterol Hepatol 2017. December 1 pii: S1542–3565(17)31418–0. doi: 10.1016/j.cgh.2017.11.045 [Epub ahead of print] - DOI - PMC - PubMed

Substances